1tes

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Nitric oxide (NO) has been implicated as mediator in a variety of, physiological functions, including neurotransmission, platelet, aggregation, macrophage function, and vasodilation. The consumption of NO, by extracellular hemoglobin and subsequent vasoconstriction have been, suggested to be the cause of the mild hypertensive events reported during, in vivo trials of hemoglobin-based O2 carriers. The depletion of NO from, endothelial cells is most likely due to the oxidative reaction of NO with, oxyhemoglobin in arterioles and surrounding tissue. In order to determine, the mechanism of this key reaction, we have measured the kinetics of, NO-induced oxidation of a variety of different recombinant sperm whale, myoglobins (Mb) and human hemoglobins (Hb). The observed rates depend, linearly on [NO] but show no dependence on [O2]. The bimolecular rate, constants for NO-induced oxidation of MbO2 and HbO2 are large (k.ox,NO =, 30-50 microM-1 s-1 for the wild-type proteins) and similar to those for, simple nitric oxide binding to deoxygenated Mb and Hb. Both reversible NO, binding and NO-induced oxidation occur in two steps: (1) bimolecular entry, of nitric oxide into the distal portion of the heme pocket and (2) rapid, reaction of noncovalently bound nitric oxide with the iron atom to produce, Fe(2+)-N=O or with Fe(2+)-O-O delta- to produce Fe(3+)-OH2 and nitrate., Both the oxidation and binding rate constants for sperm whale Mb were, increased when His(E7) was replaced by aliphatic residues. These mutants, lack polar interactions in the distal pocket which normally hinder NO, entry into the protein. Decreasing the volume of the distal pocket by, replacing Leu(B10) and Val(E11) with aromatic amino acids markedly, inhibits NO-induced oxidation of MbO2. The latter results provide a, protein engineering strategy for reducing hypertensive events caused by, extracellular hemoglobin-based O2 carriers. This approach has been, explored by examining the effects of Phe(B10) and Phe(E11) substitutions, on the rates of NO-induced oxidation of the alpha and beta subunits in, recombinant human hemoglobin.
+
Nitric oxide (NO) has been implicated as mediator in a variety of physiological functions, including neurotransmission, platelet aggregation, macrophage function, and vasodilation. The consumption of NO by extracellular hemoglobin and subsequent vasoconstriction have been suggested to be the cause of the mild hypertensive events reported during in vivo trials of hemoglobin-based O2 carriers. The depletion of NO from endothelial cells is most likely due to the oxidative reaction of NO with oxyhemoglobin in arterioles and surrounding tissue. In order to determine the mechanism of this key reaction, we have measured the kinetics of NO-induced oxidation of a variety of different recombinant sperm whale myoglobins (Mb) and human hemoglobins (Hb). The observed rates depend linearly on [NO] but show no dependence on [O2]. The bimolecular rate constants for NO-induced oxidation of MbO2 and HbO2 are large (k.ox,NO = 30-50 microM-1 s-1 for the wild-type proteins) and similar to those for simple nitric oxide binding to deoxygenated Mb and Hb. Both reversible NO binding and NO-induced oxidation occur in two steps: (1) bimolecular entry of nitric oxide into the distal portion of the heme pocket and (2) rapid reaction of noncovalently bound nitric oxide with the iron atom to produce Fe(2+)-N=O or with Fe(2+)-O-O delta- to produce Fe(3+)-OH2 and nitrate. Both the oxidation and binding rate constants for sperm whale Mb were increased when His(E7) was replaced by aliphatic residues. These mutants lack polar interactions in the distal pocket which normally hinder NO entry into the protein. Decreasing the volume of the distal pocket by replacing Leu(B10) and Val(E11) with aromatic amino acids markedly inhibits NO-induced oxidation of MbO2. The latter results provide a protein engineering strategy for reducing hypertensive events caused by extracellular hemoglobin-based O2 carriers. This approach has been explored by examining the effects of Phe(B10) and Phe(E11) substitutions on the rates of NO-induced oxidation of the alpha and beta subunits in recombinant human hemoglobin.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Physeter catodon]]
[[Category: Physeter catodon]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Jr., G.N.Phillips.]]
+
[[Category: Jr., G N.Phillips.]]
-
[[Category: Olson, J.S.]]
+
[[Category: Olson, J S.]]
-
[[Category: Smith, R.D.]]
+
[[Category: Smith, R D.]]
[[Category: ETN]]
[[Category: ETN]]
[[Category: HEM]]
[[Category: HEM]]
Line 21: Line 21:
[[Category: myoglobin (ethyl isocyanide)]]
[[Category: myoglobin (ethyl isocyanide)]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:56:37 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:12:47 2008''

Revision as of 13:12, 21 February 2008


1tes, resolution 1.7Å

Drag the structure with the mouse to rotate

OXYGEN BINDING MUSCLE PROTEIN

Overview

Nitric oxide (NO) has been implicated as mediator in a variety of physiological functions, including neurotransmission, platelet aggregation, macrophage function, and vasodilation. The consumption of NO by extracellular hemoglobin and subsequent vasoconstriction have been suggested to be the cause of the mild hypertensive events reported during in vivo trials of hemoglobin-based O2 carriers. The depletion of NO from endothelial cells is most likely due to the oxidative reaction of NO with oxyhemoglobin in arterioles and surrounding tissue. In order to determine the mechanism of this key reaction, we have measured the kinetics of NO-induced oxidation of a variety of different recombinant sperm whale myoglobins (Mb) and human hemoglobins (Hb). The observed rates depend linearly on [NO] but show no dependence on [O2]. The bimolecular rate constants for NO-induced oxidation of MbO2 and HbO2 are large (k.ox,NO = 30-50 microM-1 s-1 for the wild-type proteins) and similar to those for simple nitric oxide binding to deoxygenated Mb and Hb. Both reversible NO binding and NO-induced oxidation occur in two steps: (1) bimolecular entry of nitric oxide into the distal portion of the heme pocket and (2) rapid reaction of noncovalently bound nitric oxide with the iron atom to produce Fe(2+)-N=O or with Fe(2+)-O-O delta- to produce Fe(3+)-OH2 and nitrate. Both the oxidation and binding rate constants for sperm whale Mb were increased when His(E7) was replaced by aliphatic residues. These mutants lack polar interactions in the distal pocket which normally hinder NO entry into the protein. Decreasing the volume of the distal pocket by replacing Leu(B10) and Val(E11) with aromatic amino acids markedly inhibits NO-induced oxidation of MbO2. The latter results provide a protein engineering strategy for reducing hypertensive events caused by extracellular hemoglobin-based O2 carriers. This approach has been explored by examining the effects of Phe(B10) and Phe(E11) substitutions on the rates of NO-induced oxidation of the alpha and beta subunits in recombinant human hemoglobin.

About this Structure

1TES is a Single protein structure of sequence from Physeter catodon with , and as ligands. Full crystallographic information is available from OCA.

Reference

Mechanism of NO-induced oxidation of myoglobin and hemoglobin., Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN Jr, Olson JS, Biochemistry. 1996 Jun 4;35(22):6976-83. PMID:8679521

Page seeded by OCA on Thu Feb 21 15:12:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools